Advertisement
Home 2019 April

Monthly Archives: April 2019

The first personalized treatment for patients with metastatic bladder cancer and susceptible fibroblast growth factor receptor genetic alterations was granted accelerated approval by the U.S. Food and Drug Administration

FDA Approves Personalized Tx for Metastatic Bladder Cancer

0
Balversa indicated for treatment of bladder cancer with FGFR3 or FGFR2 genetic alteration
Daily cannabis use is more common among individuals with serious psychological distress (SPD) but is increasing in both those with and without SPD

Daily Cannabis Use More Common in Distressed Individuals

0
But use increasing among those with and without past-month serious psychological distress
Taking at least 20 minutes per day to leisurely walk or sit in a place that makes you feel in contact with nature can significantly lower stress hormone levels

Daily Dose of Nature Cuts Stress Hormone Levels

0
Only 20 minutes of nature contact shows most efficient lowering of cortisol levels
Two position statements developed in relation to drug pricing and step therapy have been issued by the American College of Rheumatology.

ACR Issues Position Statements on Drug Pricing, Step Therapy

0
Statements emphasize need for safe, convenient, affordable access to rheumatology treatments
Medication shortages are frequently reported by pharmacy practice managers

Pharmacy Practice Managers Report Frequent Drug Shortages

0
More than one-third of respondents reported no administrative methods for responding to shortages
Extragenital (rectal and pharyngeal) chlamydia and gonorrhea are prevalent among men who have sex with men

Prevalence of Extragenital STDs High in Men Who Have Sex With Men

0
Extragenital STDs mostly seen in throat and rectum, contribute to risk for drug-resistant gonorrhea and HIV
One-third of patients with cancer and cancer survivors report using complementary and alternative medicine

Complementary, Alternative Medicine Use High in Cancer Patients

0
One-third of cancer patients, survivors use CAM; 29.3 percent do not disclose CAM use to their doctor
The U.S. Centers for Disease Control and Prevention has clarified that the new guideline on prescribing opioids for chronic pain is not meant to limit access to appropriate pain management

CDC Clarifies Guideline on Opioid Prescribing for Chronic Pain

0
Clarification pertains to opioid prescribing for cancer patients, cancer survivors, sickle cell disease
Almost one in four patients with nondialysis chronic kidney disease has moderate-to-extreme pruritus

Pruritus Prevalent and Disruptive in Nondialysis Chronic Kidney Disease

0
Patients with pruritus have higher prevalence of patient-reported depression, restless sleep
From 2009 to 2015

In Pregnancy, Buprenorphine Use Up, Methadone Use Down

0
And the 4Ps Plus and SURP-P scale are sensitive for identifying illicit drug use in pregnancy